HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Robin Cornelissen Selected Research
Robin Cornelissen Research Topics
Disease
20
Neoplasms (Cancer)
04/2023 - 10/2012
20
Malignant Mesothelioma
01/2023 - 01/2016
14
Mesothelioma
01/2023 - 10/2012
9
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 12/2010
9
Lung Neoplasms (Lung Cancer)
05/2024 - 12/2010
4
Disease Progression
05/2024 - 01/2019
3
Neoplasm Metastasis (Metastasis)
01/2022 - 01/2021
2
Neutropenia
11/2021 - 01/2021
2
Pain (Aches)
01/2021 - 12/2019
2
Pleural Effusion (Pleural Effusions)
10/2017 - 01/2017
1
Hepatitis
03/2024
1
Emphysema
04/2023
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2022
1
Asthenia
01/2021
1
Cough
01/2021
1
Encephalitis (Encephalitis, Rasmussen)
01/2021
1
Fatigue
01/2021
1
Heart Failure
01/2021
1
Infections
01/2021
1
Pneumonia (Pneumonitis)
01/2021
1
Renal Insufficiency (Renal Failure)
01/2020
1
Necrosis
01/2020
1
Acute Kidney Injury (Acute Renal Failure)
01/2020
1
Acute Tubulointerstitial Nephritis
01/2020
1
Hemorrhage
12/2019
1
Pneumothorax
12/2019
1
Idiopathic Pulmonary Fibrosis
01/2019
1
Lung Diseases (Lung Disease)
01/2019
1
Circulating Neoplastic Cells
10/2017
1
Fever (Fevers)
01/2016
1
Cryptogenic Organizing Pneumonia
01/2007
1
Breast Neoplasms (Breast Cancer)
01/2007
1
Esophagitis
01/2007
1
Radiation Pneumonitis
01/2007
Drug/Important Bio-Agent (IBA)
4
Biomarkers (Surrogate Marker)
IBA
04/2023 - 10/2017
4
Asbestos
IBA
12/2022 - 12/2017
4
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2017
3
Nivolumab
IBA
05/2024 - 08/2020
3
Pemetrexed (MTA)
FDA Link
11/2021 - 12/2010
2
Tyrosine Kinase Inhibitors
IBA
01/2023 - 03/2020
2
HM781-36B
IBA
01/2023 - 01/2022
2
Antigens
IBA
05/2021 - 10/2012
2
Gemcitabine
FDA Link
02/2021 - 01/2021
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2018 - 01/2016
1
sotorasib
IBA
03/2024
1
PM 01183
IBA
09/2022
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2022
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2021
1
pembrolizumab
IBA
01/2021
1
Ipilimumab
IBA
01/2021
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2021
1
Platinum
IBA
01/2021
1
B7-H1 Antigen
IBA
08/2020
1
Talc
FDA Link
07/2020
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2020
1
pirfenidone
IBA
01/2019
1
nintedanib
IBA
01/2019
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2018
1
CD146 Antigen
IBA
10/2017
1
Proteins (Proteins, Gene)
FDA Link
01/2017
1
Ligands
IBA
01/2017
1
Antibodies
IBA
01/2017
1
Complement System Proteins (Complement)
IBA
12/2012
1
Folic Acid (Vitamin M)
FDA Link
Generic
12/2010
Therapy/Procedure
15
Immunotherapy
03/2024 - 10/2012
15
Therapeutics
01/2023 - 10/2012
11
Drug Therapy (Chemotherapy)
05/2024 - 01/2014
2
Radiotherapy
01/2021 - 01/2007
1
Segmental Mastectomy (Lumpectomy)
06/2021
1
Pleurodesis
07/2020
1
Cytoreduction Surgical Procedures
07/2020
1
Terminal Care (Care, Terminal)
03/2020
1
Chest Tubes (Chest Tube)
12/2019
1
Pneumonectomy (Lung Volume Reduction)
10/2018
1
Operative Surgical Procedures
10/2018
1
Adjuvant Chemotherapy
10/2018
1
Induction Chemotherapy
01/2014